
2024
global pct
94.7
TV Series · 2024 · TV Series · 2020s
Common Side Effects
Scored from 45 calibrated IMDb reviewers. Cohort: TV Series · 2020s (3,070 peers).
94.7%
Global percentile
vs. all 52,376 ranked titles
95.7%
In-cohort percentile
TV Series · 2020s · 3,070 titles
96.1%
AI-adjusted percentile
45 calibrated reviewers
Summary
Common Side Effects (2024) is a television series IMDb files under the animation, comedy and drama genres.
Only 45 of its IMDb reviewers are calibrated, so the calibrated figure rests on a thin sample; a broader pool of 53 reviewers with at least two reviews feeds the raw-average track. The cohort it is ranked inside is 2020s television series — 3,070 of them. Rotten Tomatoes carries a separate audience for the same title, 34 of whom clear the calibration test.
Is Common Side Effects (2024) worth watching?
- Cohort
- TV Series · 2020s · 3,070 titles
- Calibrated reviewers
- 45
Cohort: TV Series · 2020s
What else scores like Common Side Effects?
Questions about this rating
Is Common Side Effects actually good?+
Common Side Effects sits in the 94.7% percentile against all 52,376 ranked series, meaning it scores above 94.7% of them.
How does Common Side Effects compare to similar series?+
Within TV Series · 2020s, Common Side Effects lands in the 95.7% percentile. The cohort comparison exists because a global rank flatters or punishes a series for its category rather than its quality.
How many reviewers is Common Side Effects's score based on?+
45 calibrated reviewers stand behind Common Side Effects's score.



